TuHURA Biosciences (NASDAQ:HURA - Get Free Report) is expected to release its earnings data before the market opens on Wednesday, February 12th. Analysts expect TuHURA Biosciences to post earnings of ($0.11) per share for the quarter.
TuHURA Biosciences Trading Down 4.3 %
Shares of HURA stock traded down $0.19 during trading on Friday, hitting $4.27. The company had a trading volume of 173,175 shares, compared to its average volume of 218,133. TuHURA Biosciences has a one year low of $2.84 and a one year high of $14.60. The stock's 50-day simple moving average is $4.74.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. RODMAN&RENSHAW upgraded TuHURA Biosciences to a "strong-buy" rating in a research report on Thursday, December 19th. Maxim Group assumed coverage on shares of TuHURA Biosciences in a research report on Tuesday, November 5th. They issued a "buy" rating and a $15.00 target price for the company. Finally, Rodman & Renshaw assumed coverage on shares of TuHURA Biosciences in a research report on Thursday, December 19th. They set a "buy" rating and a $11.00 price target on the stock.
View Our Latest Research Report on HURA
About TuHURA Biosciences
(
Get Free Report)
TuHURA Biosciences, Inc NASDAQ: HURA is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. TuHURA's lead innate immune response agonist candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors.
Recommended Stories
Before you consider TuHURA Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TuHURA Biosciences wasn't on the list.
While TuHURA Biosciences currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
